Clinical trial
Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
NCT07296744 is registered in ClinicalTrials.gov with Supira Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Lead sponsor
- Supira Medical
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 11, 2026
- Completion date
- November 30, 2027
- Enrollment
- 358 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, high risk percutaneous coronary intervention, interventional cardiology, mechanical circulatory support